OR
Orgenesis Inc.
ORGS · OTC
$0.59 +0.00% (+$0.00)
1M +0.00%
Market Cap $5.78M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 10.91x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 58.93%
Book val. growth N/A
EPS growth N/A
Profitability
0 /100
Weak Op. margin 10,120.00%
Gross margin 1,080.19%
FCF margin 3,194.91%
Quality
1 /100
Poor Asset turnover 0.04x
ROIC 3,180.09%
ROA 380.44%
Debt
0 /100
High Int. coverage -28.74x
Current ratio 0.25x
Debt/Assets N/A
Stability
1 /100
Unstable EPS volatility 162.20%
Beta 3.14x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ORGS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Vered Caplan
Employees
77
Headquarters
Germantown
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report